{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:20:38Z","timestamp":1790371238460,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajpath.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:57:28Z","timestamp":1773763048000},"page":"1245-1258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epigenetic and Transcriptional Regulatory Networks Underlying Psoriasis Pathogenesis"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9708-1642","authenticated-orcid":false,"given":"Hemraj","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Taliyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2026.03.003_bib1","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib2","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.3390\/ijms22179294","article-title":"The role of epigenetic factors in psoriasis","volume":"22","author":"Dopytalska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib3","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","article-title":"Epigenetic modifications: basic mechanisms and role in cardiovascular disease","volume":"123","author":"Handy","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2026.03.003_bib4","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2147\/CCID.S420850","article-title":"Cellular mechanisms of psoriasis pathogenesis: a systemic review","volume":"16","author":"Wu","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib5","first-page":"82","article-title":"Psoriasis: an immunogenetic perspective","volume":"9","author":"Kocaaga","year":"2022","journal-title":"Lob Med Genet"},{"key":"10.1016\/j.ajpath.2026.03.003_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/medicina60010110","article-title":"The effects of environmental exposure on epigenetic modifications in allergic diseases","volume":"60","author":"Mija\u010d","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ajpath.2026.03.003_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3389\/fimmu.2021.756042","article-title":"Emerging role of non-coding RNAs in regulation of T-lymphocyte function","volume":"12","author":"Taheri","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib9","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.7150\/ijbs.62001","article-title":"Preclinical and clinical progress for HDAC as a putative target for epigenetic remodeling and functionality of immune cells","volume":"17","author":"Zhang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1038744","article-title":"Applications of single-cell RNA sequencing in atopic dermatitis and psoriasis","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib11","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.3390\/ijms221910841","article-title":"Skin barrier dysregulation in psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib12","first-page":"269","article-title":"Keratinocytes: innate immune cells in atopic dermatitis","volume":"205","author":"Chieosilapatham","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib13","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.3390\/ijms21155382","article-title":"Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: pathogenic implications in atopic dermatitis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1152\/physrev.00019.2013","article-title":"Transglutaminase regulation of cell function","volume":"94","author":"Eckert","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpath.2026.03.003_bib15","doi-asserted-by":"crossref","DOI":"10.4161\/21688370.2014.974451","article-title":"Epidermal tight junctions in health and disease","volume":"3","author":"Brandner","year":"2015","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ajpath.2026.03.003_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1159404","article-title":"The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update","volume":"10","author":"\u00c7etinarslan","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1365-2133.2008.08578.x","article-title":"Alterations in the desquamation-related proteolytic cleavage of corneodesmosin and other corneodesmosomal proteins in psoriatic lesional epidermis","volume":"159","author":"Simon","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00403-012-1273-x","article-title":"The association between GJB2 gene polymorphism and psoriasis: a verification study","volume":"304","author":"Liu","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ajpath.2026.03.003_bib19","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.3390\/molecules27061953","article-title":"Relationship between immune cells, depression, stress, and psoriasis: could the use of natural products be helpful?","volume":"27","author":"Alesci","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ajpath.2026.03.003_bib20","first-page":"47","article-title":"Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation","volume":"5","author":"Chistiakov","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/prd.12083","article-title":"Basic biology and role of interleukin-17 in immunity and inflammation","volume":"69","author":"Zenobia","year":"2015","journal-title":"Periodontol 2000"},{"key":"10.1016\/j.ajpath.2026.03.003_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7527953","article-title":"Neutrophil extracellular traps (NETs) and damage-associated molecular patterns (DAMPs): two potential targets for COVID-19 treatment","volume":"2020","author":"Cicco","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ajpath.2026.03.003_bib23","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1084\/jem.20160258","article-title":"Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a","volume":"213","author":"Cheung","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2026.03.003_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1017","article-title":"The role of IL-22 in the resolution of sterile and nonsterile inflammation","volume":"7","author":"Alabbas","year":"2018","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X19886505","article-title":"The role of epigenetics and immunological imbalance in the etiopathogenesis of psoriasis and psoriatic arthritis","volume":"11","author":"Frischknecht","year":"2019","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.ajpath.2026.03.003_bib26","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3389\/fimmu.2018.00954","article-title":"Human leukocyte antigen-class I alleles and the autoreactive T cell response in psoriasis pathogenesis","volume":"9","author":"Prinz","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56720","article-title":"Card14e138a signalling in keratinocytes induces TNF-dependent skin and systemic inflammation","volume":"9","author":"Manils","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.ajpath.2026.03.003_bib28","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.3390\/ijms241512310","article-title":"The genetic susceptibility to psoriasis and the relationship of linked genes to our treatment options","volume":"24","author":"Patel","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ajpath.2026.03.003_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/15476286.2023.2223486","article-title":"Implications of LncRNAs and CircRNAs in psoriasis: a review","volume":"20","author":"Shi","year":"2023","journal-title":"RNA Biol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2018.08.001","article-title":"DNA methylation as a transcriptional regulator of the immune system","volume":"205","author":"Morales-Nebreda","year":"2019","journal-title":"Transl Res"},{"key":"10.1016\/j.ajpath.2026.03.003_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.292","article-title":"Post-translational modifications of histones: mechanisms, biological functions, and therapeutic targets","volume":"4","author":"Liu","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.ajpath.2026.03.003_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target Oncol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib34","first-page":"889","article-title":"Prediction of crucial epigenetically-associated, differentially expressed genes by integrated bioinformatics analysis and the identification of S100A9 as a novel biomarker in psoriasis","volume":"45","author":"Wang","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ajpath.2026.03.003_bib35","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2340\/00015555-2926","article-title":"Ten-eleven translocation-2 regulates DNA hydroxymethylation status and psoriasiform dermatitis progression in mice","volume":"98","author":"Wang","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7731082","article-title":"Exploration of biomarkers of psoriasis through combined multiomics analysis","volume":"2022","author":"Xing","year":"2022","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ajpath.2026.03.003_bib37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jdermsci.2023.05.001","article-title":"Topical histone deacetylase 1 inhibitor entinostat ameliorates psoriasiform dermatitis through suppression of IL-17A response","volume":"110","author":"Jiang","year":"2023","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914551","article-title":"Histone and Histone acetylation-related alterations of gene expression in uninvolved psoriatic skin and their effects on cell proliferation, differentiation, and immune responses","volume":"24","author":"Romh\u00e1nyi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib39","article-title":"Novel therapeutic target(s) for psoriatic disease","volume":"9","author":"Thakur","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajpath.2026.03.003_bib40","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41419-020-03028-1","article-title":"EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2026.03.003_bib41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jmcb\/mjv022","article-title":"The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation","volume":"7","author":"Liu","year":"2015","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib42","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaci.2016.07.025","article-title":"MicroRNA-146a suppresses IL-17\u2013mediated skin inflammation and is genetically associated with psoriasis","volume":"139","author":"Srivastava","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib43","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.3390\/ijms24119130","article-title":"The essential role of microRNAs in inflammatory and autoimmune skin diseases\u2014a review","volume":"24","author":"Dopytalska","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib44","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.3892\/mmr.2017.7759","article-title":"miR-203 contributes to IL-17-induced VEGF secretion by targeting SOCS3 in keratinocytes","volume":"16","author":"Xu","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ajpath.2026.03.003_bib45","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.3390\/ijms19020530","article-title":"Role of the IL-23\/IL-17 axis in psoriasis and psoriatic arthritis: the clinical importance of its divergence in skin and joints","volume":"19","author":"Boutet","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib46","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3389\/fimmu.2019.02305","article-title":"The pathogenic role of dysregulated epigenetic modifications in autoimmune diseases","volume":"10","author":"Wu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib47","article-title":"Promising strategies in natural products treatments of psoriasis-update","volume":"10","author":"Le","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajpath.2026.03.003_bib48","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.3390\/molecules27030591","article-title":"Promising strategies in plant-derived treatments of psoriasis-update of in vitro, in vivo, and clinical trials studies","volume":"27","author":"Nowak-Perlak","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ajpath.2026.03.003_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2025.1681666","article-title":"Recent progress on DNA methylation in psoriasis","volume":"16","author":"Lin","year":"2025","journal-title":"Front Genet"},{"key":"10.1016\/j.ajpath.2026.03.003_bib50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and TH17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ajpath.2026.03.003_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688132","article-title":"Reversing post-infectious epigenetic-mediated immune suppression","volume":"12","author":"Abhimanyu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib52","article-title":"Noval advance of histone modification in inflammatory skin diseases and related treatment methods","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/genes16080940","article-title":"Histone modifications as individual-specific epigenetic regulators: opportunities for forensic genetics and postmortem analysis","volume":"16","author":"Yang","year":"2025","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ajpath.2026.03.003_bib54","first-page":"94","article-title":"Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajpath.2026.03.003_bib55","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1172\/JCI124619","article-title":"Epigenetic reprogramming of immune cells in injury, repair, and resolution","volume":"129","author":"Placek","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2026.03.003_bib56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/biomedicines13122945","article-title":"Tissue-resident memory T cells in rheumatoid immune diseases: pathogenic mechanisms and therapeutic strategies","volume":"13","author":"Tian","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpath.2026.03.003_bib57","first-page":"889","article-title":"Understanding psoriasis: role of miRNAs","volume":"45","author":"Timis","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ajpath.2026.03.003_bib58","first-page":"962","article-title":"Non-coding RNAs as key players in neurodegeneration and brain tumors: insights into therapeutic strategies.","volume":"28","author":"Saadh","year":"2025","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib59","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846612","article-title":"The long non-coding RNA LINC 00941 and SPRR 5 are novel regulators of human epidermal homeostasis","volume":"20","author":"Ziegler","year":"2019","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ajpath.2026.03.003_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102982","article-title":"Non-coding RNAs in immunoregulation and autoimmunity: technological advances and critical limitations","volume":"134","author":"Kumar","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ajpath.2026.03.003_bib61","article-title":"Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases","volume":"15","author":"Hossam","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13148-025-01999-6","article-title":"Epigenetic regulatory mechanisms of autoimmune skin diseases: novel biomarkers and therapeutic prospects","volume":"17","author":"Lai","year":"2025","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.ajpath.2026.03.003_bib63","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3389\/fphar.2019.00759","article-title":"Environmental stressors on skin aging. mechanistic insights","volume":"10","author":"Parrado","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/epigenomes4040023","article-title":"UV radiation and its relation to DNA methylation in epidermal cells: a review","volume":"4","author":"de Oliveira","year":"2020","journal-title":"Epigenomes"},{"key":"10.1016\/j.ajpath.2026.03.003_bib65","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/biomedicines10081934","article-title":"Contribution of the environment, epigenetic mechanisms and non-coding RNAs in psoriasis","volume":"10","author":"Antonatos","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpath.2026.03.003_bib66","first-page":"987","article-title":"Cigarette smoke-induced reactive oxygen species formation: a concise review","volume":"12","author":"Seo","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.ajpath.2026.03.003_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13072-019-0311-8","article-title":"The role of cigarette smoke-induced epigenetic alterations in inflammation","volume":"12","author":"Zong","year":"2019","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.ajpath.2026.03.003_bib68","article-title":"Epigenetic mechanisms of particulate matter exposure: air pollution and hazards on human health","volume":"14","author":"Gavito-Covarrubias","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.ajpath.2026.03.003_bib69","first-page":"1375","article-title":"Air pollution and microRNAs: the role of association in airway inflammation","volume":"13","author":"Furci","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ajpath.2026.03.003_bib70","doi-asserted-by":"crossref","first-page":"15637","DOI":"10.1021\/acs.est.5c01573","article-title":"Unraveling the link between air pollution and psoriasis subtypes: genetic architecture of epigenetic insights and mediating cytokines","volume":"59","author":"Leng","year":"2025","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib71","doi-asserted-by":"crossref","first-page":"335","DOI":"10.26444\/aaem\/112107","article-title":"Environmental risk factors and epigenetic alternations in psoriasis","volume":"27","author":"Roszkiewicz","year":"2020","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.ajpath.2026.03.003_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8797206","article-title":"HDAC inhibitors as epigenetic regulators of the immune system: impacts on cancer therapy and inflammatory diseases","volume":"2016","author":"Hull","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ajpath.2026.03.003_bib73","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/exd.14502","article-title":"Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis","volume":"31","author":"Samuelov","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib74","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41420-023-01399-w","article-title":"The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases","volume":"9","author":"He","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ajpath.2026.03.003_bib75","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.imbio.2014.03.013","article-title":"Histone deacetylase inhibitor valproic acid affects plasmacytoid dendritic cells phenotype and function","volume":"219","author":"Arbez","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.ajpath.2026.03.003_bib76","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.3390\/ijms21218198","article-title":"Histone deacetylase inhibitors as multitarget-directed epi-drugs in blocking PI3K oncogenic signaling: a polypharmacology approach","volume":"21","author":"Ranganna","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib77","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12967-020-02615-2","article-title":"Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review","volume":"19","author":"Landman","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajpath.2026.03.003_bib78","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/10408363.2017.1410520","article-title":"Epigenetic biomarkers: current strategies and future challenges for their use in the clinical laboratory","volume":"54","author":"Garc\u00eda-Gim\u00e9nez","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.ajpath.2026.03.003_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1245876","article-title":"DNA methylation patterns in CD4+ T-cells separate psoriasis patients from healthy controls, and skin psoriasis from psoriatic arthritis","volume":"14","author":"Natoli","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib80","first-page":"541","article-title":"The role of transcription factors in shaping regulatory T cell identity","volume":"23","author":"Trujillo-Ochoa","year":"2023","journal-title":"Nat Rev Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib81","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jid.2020.12.031","article-title":"Assay for transposase-accessible chromatin using sequencing analysis reveals a widespread increase in chromatin accessibility in psoriasis","volume":"141","author":"Tang","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib82","article-title":"Single-cell transcriptional analysis deciphers the inflammatory response of skin-resident stromal cells","volume":"9","author":"Liu","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.ajpath.2026.03.003_bib83","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s43556-023-00144-0","article-title":"Spatial transcriptomics in development and disease","volume":"4","author":"Zhou","year":"2023","journal-title":"Mol Biomed"},{"key":"10.1016\/j.ajpath.2026.03.003_bib84","first-page":"1025","article-title":"The epigenetic contribution to the pathogenesis of psoriasis: recent advances","volume":"30","author":"Aslani","year":"2023","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ajpath.2026.03.003_bib85","first-page":"321","article-title":"Reevaluating the imiquimod model: a barrier to translational progress in psoriasis","volume":"145","author":"Smith","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2026.03.003_bib86","first-page":"182","article-title":"Epigenetics-targeted drugs: current paradigms and future challenges","volume":"9","author":"Dai","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajpath.2026.03.003_bib87","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2017.09.006","article-title":"CRISPR\/Cas9-based engineering of the epigenome","volume":"21","author":"Pulecio","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ajpath.2026.03.003_bib88","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/crispr.2020.0137","article-title":"Diversification of the CRISPR toolbox: applications of CRISPR-Cas systems beyond genome editing","volume":"4","author":"Balderston","year":"2021","journal-title":"CRISPR J"},{"key":"10.1016\/j.ajpath.2026.03.003_bib89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/proteomes11040034","article-title":"Multi-omics integration for the design of novel therapies and the identification of novel biomarkers","volume":"11","author":"Ivanisevic","year":"2023","journal-title":"Proteomes"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:52:57Z","timestamp":1779274377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944026000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0002944026000660"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.03.003","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic and Transcriptional Regulatory Networks Underlying Psoriasis Pathogenesis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}